FDA warns breast biopsy needle shortage to continue into 2027

The FDA has warned that the shortage of certain breast biopsy needles is expected to persist into 2027, following Hologic's removal of these needles from the market in January. The shortage continues to impact healthcare facilities performing breast biopsies.